Rituximab in childhood lupus myocarditis

Rheumatol Int. 2012 Jun;32(6):1843-4. doi: 10.1007/s00296-011-1881-3. Epub 2011 Apr 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Child
  • Cyclophosphamide / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids / therapeutic use
  • Heart Failure / etiology
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy*
  • Myocarditis / diagnosis
  • Myocarditis / drug therapy*
  • Myocarditis / etiology
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Glucocorticoids
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide